Sinovac Life Sciences Co., Ltd.

Bldg.1, No. 21, Tianfu Street, Daxing Biomedical Industry Base, Zhongguancun Sci. Park, Daxing District, Beijing, 北京市, China

Clinical Trials

7 active

Approvals

Total approvals

Agencies

Regulatory bodies

Founded

N/A

Overview

Trial Phase Distribution

Phase

Trials

Phase 1

42.3%

Phase 3

19.2%

Phase 2

15.4%

Phase 4

15.4%

Not Applicable

7.7%

Trial Status Distribution

Active, not recruiting

11.5%

Completed

46.1%

Not yet recruiting

15.4%

Recruiting

26.9%

Clinical Trials

Trials sponsored by this organization (26)

Safety, Tolerability, Pharmacokinetics and Pharmacodynamics of SNA02-48 Injection in Chinese Adult Participants

Phase 1

Completed

interventional

Apr 2025255 participants

Page 1 of 4

Approvals

No approval data available

News

No news articles found

Back to Organizations

Sinovac Life Sciences Co., Ltd.

Overview

Trial Phase Distribution

Trial Status Distribution

Clinical Trials

Trials sponsored by this organization (26)

A Lot-to-Lot Consistency Clinical Trial of PCV13

A Phase Ⅲ Clinical Study of SNA02-48 Injection

Clinical Trial of PCV13 in Infants Aged Approximately 2 Months (42 to 89 Days)

Phase Ia Clinical Trial of Group ACYW135X Meningococcal Conjugate Vaccine

Clinical Trial of PCV24 in Infants and Children Aged 2 Months to 5 Years

Clinical Trial of PCV24 in Adults Aged ≥18 Years

Clinical Trial of PCV24 in Infants Aged 2-23 Months

Safety, Tolerability, Pharmacokinetics and Pharmacodynamics of SNA02-48 Injection in Chinese Adult Participants

Approvals

News